Inclusion Criteria:  Confirmed PCD diagnosis with identified genetic mutations Negative pregnancy test for females who are not s/p hysterectomy with oophorectomy Forced Expiratory Volume (FEV1) of at least 30 percent of predicted  Exclusion Criteria:  Any chronic medical condition considered by the PI as a contraindication to the exposure study including significant cardiovascular disease, diabetes, chronic renal disease, chronic thyroid disease, immunodeficiency, history of tuberculosis Any acute infection requiring antibiotics within 4 weeks of study. Mental illness or history of drug or alcohol abuse that, in the opinion of the investigator, would interfere with the participant's ability to comply with study requirements. Medications which may impact the results of the study treatment, or may interfere with any other medications potentially used in the study (to include steroids, beta antagonists, non-steroidal anti-inflammatory agents) Active smoking to include e-cigarettes within 1 year of the study, or lifetime of > 10 pack years of smoking History of vaping or current vaping. Allergy/sensitivity to study drugs, or their formulations. Viral upper respiratory tract infection within 4 weeks of challenge. Radiation exposure history in the past year which would be outside the safe levels Pregnant or lactating women will also be excluded since the risks associated with radiation are unknown and cannot be justified  Use of the following medications:  Use of beta blocking medications Receipt of LAIV (Live Attenuated Influenza Vaccine), also known as FluMist , within the prior 30 days, or any vaccine within the prior 5 days Multivitamins, Vitamin C or E or herbal medications in the 4 days prior to the treatment visit Non-steroidal anti-inflammatory drugs in the 4 days prior to the treatment visit. Allergy/sensitivity to study drugs or their formulations: Known Immunoglobulin E (IgE) mediated hypersensitivity to albuterol  Physical/laboratory indications:  Temperature > 37.8 degrees Celsius (C) Subjects >15 years- Systolic BP >150 mm hg or < 90 mm Hg or diastolic BP> 90 mm Hg or < 50 and Subjects 12-15 years - Systolic BP > 130 mmHg or < 80 mmHg or diastolic BP > 80 or <40 Oxygen saturation of < 93 percent Inability or unwillingness of a participant to give written informed consent.